Catherine M Broome MD

Clotting Disorder, Hemophilia & Bleeding Disorder

Associate Professor, Medicine, Georgetown University School of Medicine

3700 Reservoir RdLombardi Cancer Center Podium DWashington, DC 20007

Dr. Broome is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Broome's full profile Already have an account?

Clinical Expertise

Hematologic oncology, Bleeding disorders, Anemia, Hemolytic-uremic syndrome, Complement deficiencies, Autoimmune hemolytic anemia, Immune thrombocytopenic purpura

Education & Training

George Washington UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
Prisma Health/University of South Carolina SOM Greenville (Greenville)Residency, Internal Medicine, 1985 - 1988
LSU School of Medicine in ShreveportClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

DC State Medical License 1989 - 2028
VA State Medical License 1993 - 2022
MD State Medical License 2010 - 2020
SC State Medical License 1986 - 1993
LA State Medical License 1985 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013, 2015, 2017
CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2015, 2017
CMS Meaningful Use Stage 2 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013, 2015, 2017

Publications & Presentations

PubMed

Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatment.
Catherine M Broome, Bruno Fattizzo
Expert Review of Hematology. 2026-07-09
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-C...
Nichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, Vickie McDonald, Hanny Al-Samkari
American Journal of Hematology. 2026-07-01
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.
Bruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, Marc Michel, Carlo Visco
American Journal of Hematology. 2026-07-01

Abstracts/Posters

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicent...
Catherine M. Broome, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO (Sutimlimab-Jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual MeetingDecember 9th, 2025
Researchers Find Drug Effective to Treat Autoimmune Blood DisorderDecember 12th, 2022
After One Week, Efgartigimod Helps 38% of ITP Patients Achieve Platelet Counts to Avoid BleedingDecember 11th, 2022